These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 5579540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Aug 07; 58(30):829-30. PubMed ID: 19661857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families.
    Böttiger M, Lagercrantz R.
    J Pediatr; 1969 Jul 07; 75(1):30-8. PubMed ID: 4307138
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma.
    Willis E, Sherrod JL.
    J Natl Med Assoc; 1997 Dec 07; 89(12):785-9. PubMed ID: 9433057
    [Abstract] [Full Text] [Related]

  • 11. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA, Chilean IPV/bOPV study group.
    Lancet Infect Dis; 2015 Nov 07; 15(11):1273-82. PubMed ID: 26318714
    [Abstract] [Full Text] [Related]

  • 12. [Poliomyelitis immunization].
    Vivell O.
    Landarzt; 1967 May 31; 43(15):716-20. PubMed ID: 4305217
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Unresolved problems of poliomyelitis control].
    Vivell O.
    Dtsch Med Wochenschr; 1967 Jun 14; 92(28):1253-7. PubMed ID: 6028134
    [No Abstract] [Full Text] [Related]

  • 17. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH, Avila-Agüero ML, Brea del Castillo J, Mariño C.
    Rev Chilena Infectol; 2014 Oct 14; 31(5):590-603. PubMed ID: 25491459
    [Abstract] [Full Text] [Related]

  • 18. Leads from the MMWR. Poliomyelitis--Israel.
    JAMA; 1988 Nov 11; 260(18):2640. PubMed ID: 3184326
    [No Abstract] [Full Text] [Related]

  • 19. An appraisal of polio immunization in Nigeria and other tropical African Countries.
    Oduntan SO, Familusi JB.
    Niger Med J; 1979 Nov 11; 9(7-8):645-9. PubMed ID: 543291
    [No Abstract] [Full Text] [Related]

  • 20. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J.
    Przegl Epidemiol; 1981 Nov 11; 35(3):385-9. PubMed ID: 6276928
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.